Portfolio company
TXN Systems
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops a novel class of antibiotics to treat multidrug-resistant urinary tract infections in patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Iterum Therapeutics
This pharmaceutical company develops and commercialises oral and intravenous antibiotics for patients with multi-drug resistant infections, including urinary tract infections.
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
Calixa Therapeutics
This biopharmaceutical company develops novel antibiotics to treat serious infections caused by multi-drug-resistant pathogens for hospital patients.
BioTryp
This company develops oral antibiofilm therapies to treat bacterial infections for patients, primarily focusing on individuals with urinary tract infections.
Omnix Medical
This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.
C10 PHARMA
This biopharmaceutical company develops novel antibiotics to treat life-threatening bacterial infections and combat antimicrobial resistance for patients with unmet medical needs.
SelectX Pharmaceuticals
This biopharmaceutical company develops small molecule antimicrobials and therapeutics for unmet medical needs using a genetic chemistry platform for patients with infectious diseases.
Acurx Pharmaceuticals
This biopharmaceutical company develops small molecule antibiotics to treat patients with bacterial infections caused by priority pathogens.